Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  The Journal of Heart and Lung Transplantation

• Publication date

  1999-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1053-2498(99)00043-1PMID 10528753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.

  1998cited by this paper
• Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients.

  1998cited by this paper
• Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.

  1998cited by this paper
• Impact of humoral alloreactivity on the survival of renal allografts.

  1998cited by this paper
• The humoral immune response towards HLA class II determinants in renal transplantation.

  1996cited by this paper
• Complement regulatory molecules: application to therapy and transplantation.

  1995cited by this paper
• Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.

  1995cited by this paper
• Reliability and usefulness of immunofluorescence in heart transplantation.

  1995cited by this paper
• Complement in organ transplantation. Contributions to inflammation, injury, and rejection.

  1995cited by this paper
• Immunohistological studies of complement activation after xenogeneic perfusion of a working heart model

  1994cited by this paper
• Capillary deposition of C4d complement fragment and early renal graft loss.

  1993cited by this paper
• Immunoglobulin M antibodies in transplanted human hearts.

  1993cited by this paper
• Vascular lesions in biopsy specimens devoid of cellular infiltrates: qualitative and quantitative immunocytochemical studies of human cardiac allografts.

  1993cited by this paper
• Immunofluorescence of endomyocardial biopsy specimens: methods and interpretation.

  1993cited by this paper
• The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation.

  1993cited by this paper
• Vascular rejection in heart transplant recipients.

  1993cited by this paper
• Laparoscopic cholecystectomy in heart transplant recipients.

  1993cited by this paper
• Vascular rejection and its relationship to allograft coronary artery disease.

  1992cited by this paper
• Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies.

  1992cited by this paper
• The biology of complement.

  1991cited by this paper
• Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection.

  1991cited by this paper
• Biology of complement: the overture.

  1991cited by this paper
• Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis.

  1990cited by this paper
• Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59.

  1990cited by this paper
• A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

  1990cited by this paper
• Localization of decay accelerating factor in normal and diseased kidneys.

  1989cited by this paper
• Classical pathway of complement activation in normal and diseased human glomeruli.

  1989cited by this paper
• Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.

  1989cited by this paper
• Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.

  1989cited by this paper
• Interaction of antibodies with renal cell surface antigens.

  1989cited by this paper
• Complement activation in human lymphoid germinal centres.

  1989cited by this paper
• Acute humoral rejection after heart transplantation.

  1988cited by this paper
• Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation.

  1988cited by this paper
• The chemical structure of the C4d fragment of the human complement component C4.

  1987cited by this paper
• Lung injury mediated by antibodies to endothelium. I. In the rabbit a repeated interaction of heterologous anti-angiotensin-converting enzyme antibodies with alveolar endothelium results in resistance to immune injury through antigenic modulation

  1983cited by this paper

• Cellular Rejection Post-Cardiac Transplantation: A 13-Year Single Unicentric Study

  2025cites this paper
• On a Long and Winding Road: Alloantibodies in Organ Transplantation.

  2023cites this paper
• Is ABO-Incompatible Living Donor Liver Transplantation Really a Good Alternative for Pediatric Recipients?

  2021cites this paper
• Sheddindemg light on the problematic nature of C4d in lung transplantation -a quantitative analysis of bronchoalveolar lavage fluid.

  2020cites this paper
• [A for-cause endomyocardial biopsy during follow-up of a cardiac transplanted patient].

  2020cites this paper
• Alloimmunity in pancreas transplantation.

  2020cites this paper
• Une biopsie endomyocardique pour cause au cours du suivi d’un transplanté cardiaque

  2020cites this paper
• Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability

  2020cites this paper
• Fluctuations in circulating endothelial progenitor cell levels and acute cardiac graft rejection

  2019cites this paper
• Transplant Pathology

  2019cites this paper
• Humoral alloimmunity in cardiac allograft rejection

  2019cites this paper
• Non-invasive Myocardial Strain Imaging to Evaluate Graft Failure in Cardiac Xenotransplantation

  2017cites this paper
• Rituximab Therapy for Rejection in Pediatric Heart Transplant.

  2016cites this paper
• Pathology of Cardiac Transplantation

  2016cites this paper
• Cardiac transplant in young female patient diagnosed with diffuse systemic sclerosis.

  2016cites this paper
• Lymphatic Endothelium in Terminal Heart Failure and after Heart and Lung Transplantation

  2016cites this paper
• Cardiac transplant in young female patient diagnosed with diffuse systemic sclerosis.

  2016cites this paper
• Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?

  2016cites this paper
• C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients

  2015cites this paper
• Time-Dependent Specificity of Immunopathologic (C4d-CD68) and Histologic Criteria of Antibody-Mediated Rejection for Donor-Specific Antibodies and Allograft Dysfunction in Heart Transplantation

  2015cites this paper
• Efecto de la preservación en frío sobre el rechazo crónico en el modelo de trasplante de extremidad posterior en ratas

  2015cites this paper
• Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association.

  2015cites this paper
• Inflammatory Cell Burden and Phenotype in Endomyocardial Biopsies With Antibody‐Mediated Rejection (AMR): A Multicenter Pilot Study From the AECVP

  2015cites this paper
• Murine-Derived ABO Incompatability in Liver Transplantation

  2014cites this paper
• B CELLS AND ANTIBODY IN THE DEVELOPMENT OF LONG-TERM CARDIAC GRAFT REJECTION

  2014cites this paper
• Complement modulation in solid-organ transplantation.

  2014cites this paper
• The Role of Donor-Specific Antibodies in Acute Cardiac Allograft Dysfunction in the Absence of Cellular Rejection

  2014cites this paper
• ABO Incompatability in Liver Transplantation

  2014cites this paper
• NKG2D blockade attenuated cardiac allograft vasculopathy in a mouse model of cardiac transplantation

  2013cites this paper
• Pathologic findings in lung allografts with anti-HLA antibodies.

  2013cites this paper
• Acute Cellular and Antibody‐Mediated Rejection of the Pancreas Allograft: Incidence, Risk Factors and Outcomes

  2013influential citation
• Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.

  2012cites this paper
• NTproBNP as a marker of rejection in pediatric heart transplant recipients

  2012cites this paper
• Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection.

  2012cites this paper
• Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy.

  2012cites this paper
• The value of C4d deposit in post liver transplant liver biopsies.

  2012cites this paper
• Biomarkers of heart transplant rejection: the good, the bad, and the ugly!

  2012cites this paper
• The Diagnosis of Acute Antibody-Mediated Rejection in ABO-Incompatible Liver Transplants

  2012cites this paper
• Immediate and long-term impact of anti-graft antibodies in cardiac allografts

  2012cites this paper
• Antibody-Mediated Rejection and Early Cardiac Allograft Vasculopathy in a Child With Congenital Heart Disease

  2012influential citation
• Immediate and long-term impact of anti-graft antibodies in cardiac

  2012cites this paper
• New tissue biomarkers of Antibody Mediated Rejection in Heart Transplantation

  2012cites this paper
• 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology.

  2012cites this paper
• The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011).

  2011cites this paper
• C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?

  2011cites this paper
• Outcomes of Cardiac Transplantation in Highly Sensitized Pediatric Patients

  2011cites this paper
• Alloantibodies Prevent the Induction of Transplantation Tolerance by Enhancing Alloreactive T Cell Priming

  2011cites this paper
• Can C4d Immunostaining on Endomyocardial Biopsies Be Considered a Prognostic Biomarker in Heart Transplant Recipients?

  2010cites this paper
• Association between HLA-G expression and C4d staining in cardiac transplantation.

  2010cites this paper
• Alloreactive T Cell Priming Transplantation Tolerance by Enhancing Alloantibodies Prevent the Induction of

  2010cites this paper
• Complement Independent Antibody‐Mediated Endarteritis and Transplant Arteriopathy in Mice

  2010cites this paper
• Combined treatment with chemokine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation.

  2010cites this paper
• Controversies in defining cardiac antibody-mediated rejection: need for updated criteria.

  2010cites this paper
• The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.

  2010cites this paper
• with Chronic Rejection Allograft Acceptance and Fibrosis Associated Signaling and IL-17 in b Role of T Cell TGF

  2009cites this paper
• Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

  2009cites this paper
• Correlation of Donor‐Specific Antibodies, Complement and Its Regulators with Graft Dysfunction in Cardiac Antibody‐Mediated Rejection

  2009cites this paper
• Utility of routine immunofluorescence staining for C4d in cardiac transplant recipients.

  2009cites this paper
• with Chronic Rejection Allograft Acceptance and Fibrosis Associated Signaling and IL-17 in b Role of T Cell TGF

  2009cites this paper
• with Chronic Rejection Allograft Acceptance and Fibrosis Associated Signaling and IL-17 in b Role of T Cell TGF

  2009cites this paper
• Role of C3d and C4d complement fragments in the diagnostics of acute allograft rejection after transplantations.

  2009cites this paper
• Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.

  2009cites this paper
• Role of T Cell TGFβ Signaling and IL-17 in Allograft Acceptance and Fibrosis Associated with Chronic Rejection1

  2009cites this paper
• RETRACTED: Chronic cardiac allograft rejection in mice is alleviated by inhibition of CCR5 in combination with cyclosporine A.

  2008cites this paper
• Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch.

  2008cites this paper
• The Classical Complement Pathway in Transplantation: Unanticipated Protective Effects of C1q and Role in Inductive Antibody Therapy

  2008cites this paper
• Anti-Human Leukocyte Antigen Antibodies, Vascular C4d Deposition and Increased Soluble C4d in Broncho-Alveolar Lavage of Lung Allografts

  2008cites this paper
• De Novo Production of K-α1 Tubulin-Specific Antibodies: Role in Chronic Lung Allograft Rejection1

  2008cites this paper
• Measurement of human erythrocyte C4d to erythrocyte complement receptor 1 ratio in cardiac transplant recipients with acute symptomatic allograft failure.

  2008cites this paper
• Quilty effect areas are frequently associated with endocardial C4d deposition.

  2008cites this paper
• Characterization of C4d Immunostaining Utilizing Paraffin-Embedded Tissue of Nonpresensitized Pediatric Heart Transplant Patients

  2008cites this paper
• Acute Antibody‐Mediated Rejection Following Heart Transplantation

  2007cites this paper
• Humoral rejection in pediatric orthotopic heart transplantation.

  2007cites this paper
• Contemporary concepts in noncellular rejection.

  2007cites this paper
• A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection.

  2007cites this paper
• Chronic Cardiac Transplant Arteriopathy in Mice: Relationship of Alloantibody, C4d Deposition and Neointimal Fibrosis

  2007cites this paper
• Pancreas allograft biopsies in the management of pancreas transplant recipients: histopathologic review and clinical correlations.

  2007cites this paper
• Activation and effector function of unconventional acute rejection pathways studied in a hepatocellular allograft model

  2007cites this paper
• Fulminant acute cellular rejection with negative findings on endomyocardial biopsy.

  2006cites this paper
• Assessment of cardiac allograft vasculopathy late after heart transplantation: when is coronary angiography necessary?

  2006cites this paper
• Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition.

  2006cites this paper
• Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post‐liver transplant biopsies

  2006cites this paper
• Glomerular C3c deposition and intravascular macrophage accumulation in early humoral renal allograft rejection signifies a poor short‐term outcome

  2006cites this paper
• Acute antibody-mediated rejection of cardiac transplants.

  2006cites this paper
• [The discovery of capillary Cd4 in kidney transplantation and the "renaissance" of humoral rejection].

  2006cites this paper
• Acute humoral rejection and C4d immunostaining in ABO blood type‐incompatible liver transplantation

  2006cites this paper
• Anti‐HLA alloantibodies in pediatric solid organ transplantation

  2006cites this paper
• Trasplante cardíaco Heart transplant

  2006cites this paper
• Die Entdeckung des kapillären C4d in Nierentransplantaten und die "Renaissance" der humoralen Abstoßung

  2006cites this paper
• Antibody‐Mediated Rejection of a Pancreas Allograft

  2006cites this paper
• Rheumatoid course of humoral (vascular) rejection after heart allotransplantation

  2006cites this paper
• ALLOGRAFT VASCULOPATHY ssessment of Cardiac Allograft Vasculopathy Late After Heart ransplantation : When Is Coronary Angiography Necessary ?

  2006cites this paper
• Antibody-mediated organ-allograft rejection

  2005cites this paper
• Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy

  2005influential citation
• Mechanisms of liver allograft rejections

  2005cites this paper
• C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody.

  2005cites this paper
• Humoral Rejection of Organ Allografts

  2005cites this paper
• Staining of Pulmonary Allograft Biopsies : An mmunoperoxidase Study

  2005cites this paper
• Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies.

  2005cites this paper
• Antibody‐Mediated Rejection in Human Cardiac Allografts: Evaluation of Immunoglobulins and Complement Activation Products C4d and C3d as Markers

  2005cites this paper